Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metastatic Castration Resistant Prostate Cancer (mCRPC) × Lutetium × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Urogenital Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Diseases 1 Pheochromocytoma 1 Paraganglioma 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer (mCRPC) 1 Lung Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Digestive System Neoplasms 1 Breast Neoplasms 1

Interventions

Pluvicto 1 Lutetium-177 1 Lutetium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06894511 2026-02-17

PSMAndARPI

Novartis

Phase 2 Active not recruiting

Metastatic Castration Resistant Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡